Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| Gilead Biosciences Inc | US375558BC64 | USD | 3.25% | 2 000 USD | 31/08/2022 | Echue | |
| Gilead Biosciences Inc | US375558BW29 | USD | 0.75% | 1 000 USD | 28/09/2023 | Echue | |
| Gilead Biosciences Inc | US375558BK80 | USD | 4.15% | 2 000 USD | 28/02/2047 | 100 | |
| Gilead Biosciences Inc | US375558BS17 | USD | 2.6% | 1 000 USD | 30/09/2040 | 100 | |
| Gilead Biosciences Inc | US375558BT99 | USD | 2.8% | 1 000 USD | 30/09/2050 | 63.547 | |
| Gilead Biosciences Inc | US375558BU62 | USD | 0.332% | 1 000 USD | 16/09/2021 | Echue | |
| Gilead Biosciences Inc | US375558BV46 | USD | 0.713% | 1 000 USD | 28/09/2023 | Echue | |
| Gilead Biosciences Inc | US375558BX02 | USD | 1.2% | 1 000 USD | 30/09/2027 | 91.361 | |
| Gilead Biosciences Inc | US375558BR34 | USD | 1.85% | 2 000 USD | 19/09/2019 | Echue | |
| Gilead Biosciences Inc | US375558BJ18 | USD | 4% | 2 000 USD | 31/08/2036 | 100 | |
| Gilead Biosciences Inc | US375558BQ50 | USD | 0% | 2 000 USD | 19/09/2019 | Echue | |
| Gilead Biosciences Inc | US375558BP77 | USD | 3.012% | 2 000 USD | 19/03/2019 | Echue | |
| Gilead Biosciences Inc | US375558AW38 | USD | 3.7% | 2 000 USD | 31/03/2024 | Echue | |
| Gilead Biosciences Inc | US375558AV54 | USD | 2.05% | 2 000 USD | 31/03/2019 | Echue | |
| Gilead Biosciences Inc | US375558AX11 | USD | 4.8% | 2 000 USD | 31/03/2044 | 91.96 | |
| Gilead Biosciences Inc | US375558BZ59 | USD | 5.25% | 14/10/2033 | 104.66 | ||
| Gilead Biosciences Inc | US375558CE12 | USD | 5.6% | 14/11/2064 | 99.94 | ||
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, primarily focusing on HIV/AIDS, hepatitis B and C, and oncology.
Gilead Sciences est une société biopharmaceutique mondiale spécialisée dans la découverte, le développement et la commercialisation de traitements contre des maladies graves, notamment le VIH, l'hépatite et le cancer.
Gilead Sciences Inc. è una società biofarmaceutica multinazionale focalizzata sulla scoperta, lo sviluppo e la commercializzazione di farmaci antivirali, oncologici e per malattie infiammatorie.